Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond
Virtual Event : 24 - 25 February 2026
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Chair: Maria Caffarel
Raymond Schiffelers UMC Utrecht, Netherlands
'Targeted lipid nanoparticles delivering DNA for in vivo CAR T cell engineering'
Q&A 12:25-12:35
Pablo Menendez Josep Carreras Leukaemia Research Institute, Spain
'Armoured-CAR T cell-redirecting immunotherapy for metastatic and refractory Ewing Sarcoma'
Q&A 12:55-13:05
Chiara Caprioli KU Leuven, Belgium
Proffered Paper 1: 'Unraveling Response to Dendritic Cell Vaccination in Glioblastoma by Spatial Transcriptomics Profiling'
Q&A 13:15-13:20
Myrofora Panagi University of Cyprus, Cyprus
Proffered Paper 2: ‘Engineering the tumor microenvironment with programmable bacteria to enhance immunotherapy’
Q&A 13:30-13:35
INDUSTRY SPOTLIGHT - Lightcast
Scott Brouilette Lightcast
'Envisia: single-cell phenotypic profiling'
REFRESHMENT BREAK
Chair: Federica Sallusto
FLASH TALKS 1
Marleen Kok NKI, Netherlands
'Tumor dynamics during immunotherapy response in breast cancer'
Q&A 14:30-14:40
Luna Ridan Cordeiro Minute Hospital la Paz Institute for Health Research, Spain
Proffered Paper 3: ‘MV130 as a new innate memory-based immunotherapy against cancer’
Q&A 14:50-14:55
REFRESHMENT BREAK
Chair: Toni Celià-Terrassa
FLASH TALKS 2
Pietro Paolo Vitiello IFOM, Italy
Proffered Paper 4: 'The combination of cisplatin and temozolomide triggers immune surveillance through antigen-dependent and independent mechanisms'
Q&A 15:30-15:35
Adriaan de Groot Netherlands Cancer Institute, Netherlands
Proffered Paper 5: 'CD28 glyco-editing augments CD8 T cell:tumor cell interaction and killing’
Q&A 15:45-15:50
CLOSING KEYNOTE
Nathan West Genentech, USA
'Emerging cytokine-based strategies for cancer immunotherapy'
Q&A 16:20-16:35
SUMMARY AND CLOSE
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
Chair: Arianna Calcinotto
Joaquin Arribas Hospital del Mar Research Institute, Spain
'Turning HER2-Amplified Tumors into CAR-T Responders'
Q&A 12:25-12:35
EMBO Keynote Lecture
Eric Vivier Centre d’Immunologie de Marseille-Luminy, France
'Harnessing NK cells in cancer therapies'
Q&A 12:55-13:05
Marco Piva CIC BIoGUNE, Spain
Proffered Paper 6: 'A novel androgen-responsive metastatic prostate cancer model for rational combination immunotherapy'
Q&A 13:15-13:20
Margo De Velder Ghent University, Belgium
Proffered Paper 7: ‘mRNA lipid nanoparticles alter myeloid cell dynamics in the 4T1 tumor microenvironment’
Q&A 13:30-13:35
REFRESHMENT BREAK
Chair: Toni Celià-Terrassa
FLASH TALKS 3
Victor Peperzak University Medical Center Utrecht, Netherlands
Proffered Paper 8: ‘Enhancing CAR T cell cytotoxicity through targeted delivery of pro-apoptotic cargo’
Q&A 14:15-14:20
Alena Gros VHIO, Spain
'Towards personalized antitumor T-cell therapies from peripheral blood'
Q&A 14:40-14:50
REFRESHMENT BREAK
FLASH TALKS 4
Arianna Calcinotto Institute of Oncology Research, Switzerland
'Neutrophils in cancer: heterogeneous and multifaceted'
Q&A 15:35-15:45
Nicolae Ciobu Zubenco Columbia University, USA
Proffered Paper 9: 'Lipid desaturation as a metabolic checkpoint for T cell immunity suppression in liver cancer'
Q&A 15:55-16:00
DISCUSSION SESSION
Maria Caffarel, Nathan West, Joaquin Arribas
"How to translate the next generation immunotherapies to the clinic?"
CONFERENCE SUMMARY AND CLOSE
Key dates
Abstract submission deadline:
12 January 2026
Registration and Payment deadline:
02 February 2026
